The dynamic changement of three markers may be used to predict the trends of diseases and select effective medicine treating hepatic fibrosis.
动态观察上述指标的变化既可掌握患者病情的演变，也为抗肝纤维化药物的筛选奠定基础。
Conclusions Ultrasonography quantitative scoring system, especially when it is combined with serum fibrosis markers, has a higher value in noninvasive quantitative diagnosis of hepatic fibrosis.
结论超声积分及超声与血清肝纤维化指标联合应用对肝纤维化无创定量诊断有较高的价值。
METHODS:The change of serum liver fibrosis markers and hepatic function were observed in treatment group and control group before and after treatment.
方法：观察治疗组及对照组治疗前、后血清肝纤维化标志物、肝功能的变化。
METHODS:The change of serum liver fibrosis markers and hepatic function were observed in treatment group and control group before and after treatment.
方法：观察治疗组及对照组治疗前、后血清肝纤维化标志物、肝功能的变化。
应用推荐